Loading candles…
Ipca Laboratories Ltd. is a vertically integrated pharmaceutical company engaged in the manufacturing and marketing of pharmaceuticals, including Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs). The company operates in the pharmaceutical industry, serving both the Indian domestic market and various international markets. Its product portfolio includes APIs and FDFs focused on therapeutic areas such as pain management, rheumatology, antimalarials, and cardiovascular health. A significant portion of its revenue is derived from exports. The company’s operations cover the entire value chain in pharmaceuticals, reflecting its integrated business segments of API and FDF manufacturing.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 29 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 13 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 13 Nov 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 11 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and Final dividend | 29 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.